Authors: von Itzstein, Mitchell S., Yuqiu Yang, Yiqing Wang, Hsiehchen, David, Sheffield, Thomas Y., Fattah, Farjana, Popat, Vinita, Ahmed, Murtaza, Homsi, Jade, Dowell, Jonathan E., Rashdan, Sawsan, Lohrey, Jay, Hammers, Hans J., Hughes, Randall S., Tao Wang, Yang Xie, Gerber, David E.
Superior Title: Frontiers in Immunology; 2024, p1-8, 8p
Authors: Ulndreaj, Antigona, Brinc, Davor, Altan, Mehmet, Pons-Belda, Oscar D., Fernandez-Uriarte, Amaia, Mu-Mosley, Hong, Fattah, Farjana, von Itzstein, Mitchell S., Soosaipillai, Antoninus, Kulasingam, Vathany, Palaskas, Nicolas L., Gerber, David E., Diamandis, Eleftherios P., Heymach, John V., Prassas, Ioannis
Superior Title: Clinical Chemistry & Laboratory Medicine; Jan2023, Vol. 61 Issue 1, p154-161, 8p
Authors: von Itzstein, Mitchell S., Gonugunta, Amrit S., Wang, Yiqing, Sheffield, Thomas, Lu, Rong, Ali, Sadia, Fattah, Farjana J., Xie, Donglu, Cai, Jennifer, Xie, Yang, Gerber, David E.
Superior Title: Cancer Immunology, Immunotherapy; Sep2022, Vol. 71 Issue 9, p2169-2181, 13p
Authors: Hsiehchen, David, Naqash, Abdul Rafeh, Espinoza, Magdalena, Von Itzstein, Mitchell S., Cortellini, Alessio, Ricciuti, Biagio, Owen, Dwight H., Laharwal, Mehak, Yukihiro Toi, Burke, Michael, Yang Xie, Gerber, David E.
Superior Title: OncoImmunology; 2022, Vol. 11 Issue 1, p1-8, 8p
Authors: Brown, Timothy J., Keshvani, Neil, Gupta, Arjun, Yang, Hui, Agrawal, Deepak, Le, Tri C., Gerber, David E., Alvarez, Carlos A.
Superior Title: Supportive Care in Cancer; Nov2020, Vol. 28 Issue 11, p5315-5321, 7p
Subject Terms: LUNG cancer, PREVENTIVE medicine, CONSTIPATION, COHORT analysis, DRUG side effects, CANCER pain
Authors: Lieu, Christopher H., Hidalgo, Manuel, Berlin, Jordan D., Ko, Andrew H., Cervantes, Andres, LoRusso, Patricia, Gerber, David E., Eder, J. Paul, Eckhardt, S. Gail, Kapp, Amy V., Tsuhako, Amy, McCall, Bruce, Pirzkall, Andrea, Uyei, Anne, Tabernero, Josep
Superior Title: Oncologist; Sep2017, Vol. 22 Issue 9, p1024-1024, 7p, 12 Charts
Subject Terms: EVALUATION of clinical trials, CANCER treatment, METASTASIS, COMBINATION drug therapy, DIARRHEA, DRUG side effects, CLINICAL drug trials, DRUG toxicity, GENES, HYPOKALEMIA, MONOCLONAL antibodies, GENETIC mutation, ONCOLOGY, PAIN, PATIENT safety, PROTEINS, RESEARCH, RESEARCH funding, TERMINATION of treatment, PATIENT selection, PROTEIN kinase inhibitors